Issue for Week of January 25, 2004 / Vol. 4 No. 01

Study: Actimmune Fails to Reverse Liver Damage in Hepatitis C Patients FDA Approves Oral Rebetol Plus Intron A for Children With Hepatitis C Study Provides Greater Understanding of How Viruses Like Hepatitis C Cause Infection